MedPath

The effect of Cognitive Behavioral Therapy (CBT) on sexual function and satisfaction of women with breast cancer

Not Applicable
Conditions
Sexual function of women with breast cancer.
Malignant neoplasm of breast
Registration Number
IRCT20180616040113N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
42
Inclusion Criteria

Women with breast cancer after mastectomy
Score less than 26.5 of female sexual function index questionnaire
Married
To have sexual relation with husband
To have minimum one child
After complete of chemotherapy course
Diagnosis of breast cancer 6 month till 5 years before present in research
Ability to attend in group therapy session
Having at least elementary education
Score less than 75 of Larson sexual satisfaction questionnaire
Reproductive ages 18-49 years

Exclusion Criteria

Pregnancy and lactation
Chronic diseases such as hypertension, diabetes and thyroid disease, and autoimmune diseases
Menopause
Taking antipsychotic drugs during the past 6 months
Psychiatric disorders
Use of Hormone Replacement Therapy (HRT)
Drug addiction or alcohol dependence or psychoactive materials based on personal comments
Treatment another type of cancer or malignancy
Participate in concurrent therapy programs to reduce sexual problems and reduce other psychological problems
The occurrence of a unpleasant event during the last 6 months
Hysterectomy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sexual function of women with breast cancer. Timepoint: Before the intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Sexual satisfaction. Timepoint: Before the intervention- 8 weeks after intervention. Method of measurement: Larson sexual satisfaction questionnaire.
Secondary Outcome Measures
NameTimeMethod
Sexual desire. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Sexual arousal. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Vaginal Lubrication. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Orgasm. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Dyspareunia. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.;Sexual pleasure. Timepoint: Before intervention- 8 weeks after intervention. Method of measurement: Female sexual function index questionnaire.
© Copyright 2025. All Rights Reserved by MedPath